Vincent Lo Re, MD, MSCE is Professor of Medicine in the Division of Infectious Diseases of the Robert Wood Johnson Medical School of Rutgers University and Director of the Rutgers Center for Pharmacoepidemiology and Treatment Science within the Rutgers Institute for Health. Dr. Lo Re leads an NIH-funded research program focused on pharmacoepidemiology research.
Dr. Jonathan Sexton is faculty in the Department of Internal Medicine in the Division of Gastroenterology and Hepatology, and the College of Pharmacy, Medicinal Chemistry at the University of Michigan. Dr. Sexton is a translational scientist with expertise in artificial intelligence-enhanced drug discovery and development. His research focuses on advancing lead compounds toward clinical applications in various therapeutic areas, particularly in liver and gastrointestinal diseases.
Dr. Amar Bansal is a nephrologist and palliative care physician at the University of Pittsburgh. He is the Associate Program Director for the nephrology training program. He has an interest in serious illness communication. He is the course director for "GiTalk," a communication workshop based on VitalTalk designed for GI providers. It is held annually for GI fellows and APP's at UPMC/Pitt.
Dr. Gedallovich is a gastroenterologist and transplant hepatologist, practicing as a Clinical Assistant Professor at Stanford University. Prior to this, she completed Gastroenterology and Transplant Hepatology fellowships at Stanford University and Hospice & Palliative Medicine fellowship at the University of California San Francisco. She is passionate about the integration of palliative medicine into the care of patients with advanced liver disease.
Assistant Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Transplant Hepatologist at the Northwell Health Center for Liver Disease and Transplantation with a focus on Palliative Care and Care Coordination. I completed my Hospice & Palliative Medicine, Gastroenterology, and Transplant Hepatology training at Mount Sinai Hospital.
Cristal Brown, MD, MHS is a transplant hepatologist and Assistant Professor of Medicine at the University of Texas at Austin Dell Medical School. As a physician-scientist, Dr. Brown focuses on interventions to help eliminate health disparities throughout the trajectory of end-stage liver disease.
Dr. Jessica Hartman is an Associate Professor in the Department of Biochemistry and Molecular Biology and the Department of Regenerative Medicine at the Medical University of South Carolina. Dr. Hartman completed her Ph.D. with the support of a NSF GRFP fellowship at the University of Arkansas for Medical Sciences in the lab of Dr. Grover Miller studying enzyme kinetics of substrate oxidation by cytochrome P450 2E1 (CYP2E1). She then went on to do a NIEHS F32-supported postdoctoral fellowship with Dr.
Danielle M. Tholey, MD is a Transplant Hepatologist and an Associate Professor at Thomas Jefferson University/Sidney Kimmel Medical College. Dr. Tholey serves as the Program Director of Jefferson's Transplant Hepatology fellowship and the Medical Director of the Live Donor Liver Transplantation program. She is passionate about medical education and is also a course instructor at the Sidney Kimmel Medical College. Her clinical and research interests include living donor liver transplantation, post liver transplant outcomes, liver diseases of pregnancy and global health.
Dr. Kleiner obtained an M.D. and Ph.D. (Chemistry) from the University of Chicago. After a residency in Anatomic Pathology at the National Cancer Institute, he joined the faculty of the Laboratory of Pathology in the NCI. He is currently a Senior Research Physician and Chief of the Postmortem Section of the Laboratory of Pathology with expertise in hepatic pathology. His research has focused on chronic liver disease, drug-induced liver injury and liver cancer, with particular attention to assessing histological responses to therapy.